Gene therapy for XSCID: The first success of gene therapy

被引：6
|
作者：
Kohn, DB [1 ]
机构：
[1] Childrens Hosp Los Angeles, Div Res Immunol Bone Marrow Transplantat, Los Angeles, CA 90027 USA
来源：
PEDIATRIC RESEARCH | 2000年 / 48卷 / 05期
关键词：
D O I：
10.1203/00006450-200011000-00002
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：578 / 578
页数：1
相关论文
共 50 条
  • [1] Gene Therapy for XSCID: The First Success of Gene Therapy
    Donald B Kohn
    Pediatric Research, 2000, 48 : 578 - 578
  • [2] First Success with Gene Therapy
    不详
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2014, 231 (03) : 200 - 200
  • [3] Gene silencing as a threat to the success of gene therapy
    Bestor, TH
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04): : 409 - 411
  • [4] Gene therapy success in cancer
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (10) : 808 - 808
  • [5] Small success for gene therapy
    Alan Dove
    Nature Biotechnology, 2000, 18 : 592 - 593
  • [6] Small success for gene therapy
    Dove, A
    NATURE BIOTECHNOLOGY, 2000, 18 (06) : 592 - 593
  • [7] A SUCCESS FOR GENE-THERAPY
    COOK, JS
    NEWS IN PHYSIOLOGICAL SCIENCES, 1994, 9 : 99 - 99
  • [8] Gene therapy for hemophilia: advancing beyond the first clinical success
    Monahan, Paul E.
    Gui, Tong
    CURRENT OPINION IN HEMATOLOGY, 2013, 20 (05) : 410 - 416
  • [9] Development of XSCID gene therapy for B-cell defective post-transplant XSCID patients.
    Tsai, EJ
    Aviles-Medoza, GJ
    Band, JM
    Anderson, SM
    Outsu, M
    Candotti, F
    Bodine, DM
    Malech, HL
    Puck, JM
    BLOOD, 2000, 96 (11) : 845A - 845A
  • [10] Development of XSCID gene therapy for posttransplant patients with persistent immune defects.
    Puck, JM
    Tsail, EJ
    Levin, T
    Kirby, MR
    Hsu, AP
    Seidel, NE
    Porada, C
    Zanjani, E
    Bodine, DM
    Malech, HL
    BLOOD CELLS MOLECULES AND DISEASES, 2002, 28 (03) : 343 - 343
12345